Guyana vs North Macedonia: Number of confirmed cases of tetanus
Guyana
0 Cases
in 2024
North Macedonia
0 Cases
in 2024
Guyana rank
108th
North Macedonia rank
108th
Number of confirmed cases of tetanus over time
- Guyana
- North Macedonia
How they compare
Guyana currently reports 0 Cases against 0 Cases in North Macedonia, a difference of 0 Cases.
The two have swapped places 6 times across 28 shared years of data; in 1991 it was North Macedonia ahead.
Guyana ranks 108th and North Macedonia ranks 108th of 210 countries.
Across the 4 decades both report, Guyana averaged higher in 2 and North Macedonia in 1.
Head to head by decade
| Decade | Guyana | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.17 Cases | 1.67 Cases | 0.5 Cases | North Macedonia |
| 2000s | 202 Cases | 0.5 Cases | 201.5 Cases | Guyana |
| 2010s | 0.7143 Cases | 0.4286 Cases | 0.2857 Cases | Guyana |
| 2020s | 0 Cases | 0 Cases | 0 Cases | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of confirmed cases of tetanus, Guyana or North Macedonia?
- Guyana, at 0 Cases against 0 Cases in North Macedonia as of 2024.
- What is the difference in number of confirmed cases of tetanus between Guyana and North Macedonia?
- 0 Cases, with Guyana ahead.
- How many years of comparable data are there for Guyana and North Macedonia?
- 28 years are reported by both, from 1991 to 2024.
- How do Guyana and North Macedonia rank globally for number of confirmed cases of tetanus?
- Guyana ranks 108th and North Macedonia ranks 108th of 210 countries.
- Where does this data come from?
- World Health Organization – Global Health Observatory (2026) – with minor processing by Our World in Data, published as Number of confirmed cases of tetanus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The annual number of confirmed cases of tetanus. Confirmed numbers underestimate the actual number of tetanus cases, due to limited testing and reporting capacity.